Literature DB >> 8854129

Sickle cell gene in the population of Saudi Arabia.

M A el-Hazmi1, A S Warsy, A R al-Swailem, A M al-Swailem, H M Bahakim.   

Abstract

A comprehensive screening program was initiated in Saudi Arabia in 1982 to determine the frequency of the sickle cell (Hb S) gene in the different regions of Saudi Arabia. Over a period of 10 years 30,055 samples were collected from 36 areas in the five provinces of Saudi Arabia; these were screened using electrophoretic techniques in alkaline and acid pH for the presence of Hb S in heterozygous and homozygous states. The overall prevalence of Hb AS was 7.36% and Hb SS was 1.06%, giving an Hb S gene frequency of 0.047. The results from the different regions were separated and the prevalence of Hb AS and Hb SS and Hb S gene frequencies were calculated in each province and each region. The prevalence of Hb AS and Hb SS cases ranged from O to 25.88% and O to 5.27%, respectively. No case of Hb AS or Hb SS were identified in certain areas of the central province (Al-Russ, Al-Unaiza, Al-Mesnab and Bkaria) and northern province (Qurayat and Al-Jouf). In the southern province both Hb S homozygotes and heterozygotes were encountered in all regions except Farasan Island. In all other regions the Hb S gene was encountered, but at a variable frequency. Applying Hardy-Weinberg equilibrium it was observed that in the majority of the regions the observed Hb S homozygotes were significantly higher compared to the number expected (p < 0.0001). This was believed to be due to bias as the samples were collected in the hospital. The Hb S gene frequency in the different regions ranged from 0 to 0.17 when the frequency was calculated on the basis of both Hb AS and Hb. SS cases, and 0 to 0.13 if the gene frequency was calculated after eliminating the Hb SS cases. A close correlation was observed between the Hb S gene frequency and malaria endemicity. This study shows that the Hb S gene occurs frequently in several regions of Saudi Arabia and there is an urgent need to implement control and prevention programs to reduce the number of Hb S homozygous cases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8854129     DOI: 10.3109/03630269609027928

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  4 in total

1.  Echocardiographic evaluation of left ventricular diastolic and systolic function in Saudi patients with sickle cell disease.

Authors:  Mohammed Fakhry Abdul-Mohsen
Journal:  J Saudi Heart Assoc       Date:  2012-06-12

2.  Prevalence of glucose-6-phosphate dehydrogenase deficiency and sickle cell trait among blood donors in Riyadh.

Authors:  Mohammed K Alabdulaali; Khaled M Alayed; Abdulaziz F Alshaikh; Shihab A Almashhadani
Journal:  Asian J Transfus Sci       Date:  2010-01

Review 3.  Sickle cell disease in Middle East Arab countries.

Authors:  Mohsen A F El-Hazmi; Ali M Al-Hazmi; Arjumand S Warsy
Journal:  Indian J Med Res       Date:  2011-11       Impact factor: 2.375

4.  Sickle cell disease patients in eastern province of Saudi Arabia suffer less severe acute chest syndrome than patients with African haplotypes.

Authors:  M K Alabdulaali
Journal:  Ann Thorac Med       Date:  2007-10       Impact factor: 2.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.